Purpose: To assess early and late micromorphological modifications of cross-linked corneas in vivo by means of Heidelberg Retinal Tomography (HRT) II confocal microscopy. Design: Prospective nonrandomized open trial. Methods: Micromorphological examination of 44 cross-linked keratoconic corneas was performed in vivo by HRT II confocal laser scanning microscopy. Riboflavin ultraviolet (UV)-A-induced corneal collagen cross-linking (CXL) was performed according to the Siena protocol: pilocarpin 1% drops 30 minutes before, topical anesthesia with lidocaine 4% drops 15 minutes before irradiation, mechanical scraping of epithelium (9-mm-diameter area), preirradiation soaking for 10 minutes in riboflavin solution 0.1% (Ricrolin, Sooft, Italy) appl...
Purpose: To determine whether corneal cross-linking (CXL) with individualized fluence (“sub400 proto...
PURPOSE: To assess the effectiveness of riboflavin-ultraviolet type A rays induced cross-linking...
To report the outcomes after corneal collagen cross-linking (CXL) treatment with riboflavin and ultr...
Purpose: To assess early and late micromorphological modifications of cross-linked corneas in vivo b...
Purpose: To assess early and late micromorphological modifications of cross-linked corneas in vivo b...
PURPOSE: To assess ultrastructural stromal modifications after riboflavin-UVA-induced cross-linking ...
PURPOSE. To assess corneal tissue modifications after riboflavin-UVA- induced cross-linking of corne...
Purpose: To assess qualitative micro-morphological corneal changes by confocal microscopy and cornea...
Purpose: To investigate the correlations between corneal structural modifications assessed by in viv...
Purpose: To investigate the correlations between corneal structural modifications assessed by in viv...
Abstract Purpose: To report structural changes observable in in vivo confocal microscopy (IVCM) in k...
PURPOSE: Riboflavin/ultraviolet A (UVA) cross-linking (CXL) of corneal collagen is a novel method of...
Purpose: To report structural changes observable in in vivo confocal microscopy (IVCM) in keratoconi...
Purpose. To report the 12-month outcomes of corneal collagen cross-linking (CXL) with a hypoosmolar ...
We report the first pilot qualitative confocal microscopic analysis of a laser in situ keratomileusi...
Purpose: To determine whether corneal cross-linking (CXL) with individualized fluence (“sub400 proto...
PURPOSE: To assess the effectiveness of riboflavin-ultraviolet type A rays induced cross-linking...
To report the outcomes after corneal collagen cross-linking (CXL) treatment with riboflavin and ultr...
Purpose: To assess early and late micromorphological modifications of cross-linked corneas in vivo b...
Purpose: To assess early and late micromorphological modifications of cross-linked corneas in vivo b...
PURPOSE: To assess ultrastructural stromal modifications after riboflavin-UVA-induced cross-linking ...
PURPOSE. To assess corneal tissue modifications after riboflavin-UVA- induced cross-linking of corne...
Purpose: To assess qualitative micro-morphological corneal changes by confocal microscopy and cornea...
Purpose: To investigate the correlations between corneal structural modifications assessed by in viv...
Purpose: To investigate the correlations between corneal structural modifications assessed by in viv...
Abstract Purpose: To report structural changes observable in in vivo confocal microscopy (IVCM) in k...
PURPOSE: Riboflavin/ultraviolet A (UVA) cross-linking (CXL) of corneal collagen is a novel method of...
Purpose: To report structural changes observable in in vivo confocal microscopy (IVCM) in keratoconi...
Purpose. To report the 12-month outcomes of corneal collagen cross-linking (CXL) with a hypoosmolar ...
We report the first pilot qualitative confocal microscopic analysis of a laser in situ keratomileusi...
Purpose: To determine whether corneal cross-linking (CXL) with individualized fluence (“sub400 proto...
PURPOSE: To assess the effectiveness of riboflavin-ultraviolet type A rays induced cross-linking...
To report the outcomes after corneal collagen cross-linking (CXL) treatment with riboflavin and ultr...